Coupled to a significant DOT1L specificity in comparison with other lysine methyltransferases, EPZ004777 showed a surprising ability to selectively inhibit proliferation of MLL-rearranged cells, decreasing H3K79 methylation level and inducing a profound transcriptome deregulation of cancer cells (Daigle et al., 2011). This evidence concerns the gene DOT1L and cancer.